These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28591212)

  • 41. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
    Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
    Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial activation, haemostasis and thrombosis biomarkers in Ugandan children with severe malaria participating in a clinical trial.
    Graham SM; Chen J; Chung DW; Barker KR; Conroy AL; Hawkes MT; Namasopo S; Kain KC; López JA; Liles WC
    Malar J; 2016 Feb; 15():56. PubMed ID: 26830467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
    van den Born BJ; van der Hoeven NV; Groot E; Lenting PJ; Meijers JC; Levi M; van Montfrans GA
    Hypertension; 2008 Apr; 51(4):862-6. PubMed ID: 18332284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Determination of ADAMTS13 antigen and activity levels in patients with acute myocardial infarction and acute ischemic stroke].
    Dong NZ; Liu F; Ji SD; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):161-3. PubMed ID: 18788613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Von Willebrand factor: another janus-faced hemostasis protein.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
    Catto AJ; Carter AM; Barrett JH; Bamford J; Rice PJ; Grant PJ
    Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.
    Samai A; Monlezun D; Shaban A; George A; Dowell L; Kruse-Jarres R; Schluter L; El Khoury R; Martin-Schild S
    Stroke; 2014 Sep; 45(9):2789-91. PubMed ID: 25028444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
    Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
    Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation.
    Freynhofer MK; Bruno V; Jarai R; Gruber S; Höchtl T; Brozovic I; Farhan S; Wojta J; Huber K
    Thromb Haemost; 2011 Mar; 105(3):435-43. PubMed ID: 21136020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.
    Yang J; Wu Z; Long Q; Huang J; Hong T; Liu W; Lin J
    Front Immunol; 2020; 11():610696. PubMed ID: 33343584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
    Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
    Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis.
    Habe K; Wada H; Higashiyama A; Akeda T; Tsuda K; Mori R; Kakeda M; Matsumoto T; Ohishi K; Yamanaka K; Katayama N; Mizutani H
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):920-927. PubMed ID: 29130325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
    Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
    Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis.
    Haybar H; Khodadi E; Kavianpour M; Saki N
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):176-181. PubMed ID: 29669506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
    Singh K; Kwong AC; Madarati H; Kunasekaran S; Sparring T; Fox-Robichaud AE; Liaw PC; Kretz CA
    PLoS One; 2021; 16(2):e0247017. PubMed ID: 33606732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.
    Karakaya B; Tombak A; Serin MS; Tiftik N
    Hematology; 2016 Jun; 21(5):295-9. PubMed ID: 26872106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.